CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Shares withheld for taxes President and CEO gave up 3,455 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,480 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,480 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Reg & Develop Officer gave up 1,480 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 1,153 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 1,974 shares (to pay taxes)
- 4 Open-market buy Chief Financial Officer bought 1,250 shares at $18.22 ($22,775)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Financial Officer bought 1,250 shares at $16.59 ($20,738)
- 4 Open-market buy Director bought 26,700 shares at $16.54 ($441,618)
- 4 Open-market sale Director sold 2,300 shares at $16.52 ($37,996)
- 4 Open-market buy President and CEO bought 10,000 shares at $16.75 ($167,500)
- 4 Exercise or conversion Director acquired 2,377 shares (option exercise)
- 4 Other disposition Director disposed of 94,151 shares (other)
- 4 Other acquisition Chief Legal Officer acquired 9,018 shares (other)
- 4 Other acquisition Chief Financial Officer acquired 9,018 shares (other)
- 4 Other acquisition President and CEO acquired 9,018 shares (other)
- 4 Derivatives Options or other derivatives
Page 16 of 21 · 414 filings